1. 2022
  2. Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT

    Santos, R. D., Ruzza, A., Hovingh, G. K., Stefanutti, C., Mach, F., Descamps, O. S., Bergeron, J., Wang, B., Bartuli, A., Buonuomo, P. S., Greber-Platzer, S., Luirink, I., Bhatia, A. K., Raal, F. J., Kastelein, J. J. P., Wiegman, A. & Gaudet, D., 1 Oct 2022, In: The Lancet Diabetes and Endocrinology. 10, 10, p. 732-740 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis

    van Bergen en Henegouwen, K., Hutten, B. A., Luirink, I. K., Wiegman, A., de Groot, E. & Kusters, D. M., 1 Mar 2022, In: Journal of clinical lipidology. 16, 2, p. 128-142 15 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. 2021
  5. Marked plaque regression in homozygous familial hypercholesterolemia

    Reeskamp, L. F., Nurmohamed, N. S., Bom, M. J., Planken, R. N., Driessen, R. S., van Diemen, P. A., Luirink, I. K., Groothoff, J. W., Kuipers, I. M., Knaapen, P., Stroes, E. S. G., Wiegman, A. & Hovingh, G. K., 1 Jun 2021, In: Atherosclerosis. 327, p. 13-17 5 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. 2020
  7. Evolocumab in pediatric heterozygous familial hypercholesterolemia

    Santos, R. D., Ruzza, A., Hovingh, G. K., Wiegman, A., Mach, F., Kurtz, C. E., Hamer, A., Bridges, I., Bartuli, A., Bergeron, J., Szamosi, T., Santra, S., Stefanutti, C., Descamps, O. S., Greber-Platzer, S., Luirink, I., Kastelein, J. J. P. & Gaudet, D., 1 Oct 2020, In: New England journal of medicine. 383, 14, p. 1317-1327 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Hyperinsulinism in a patient with a Zellweger Spectrum Disorder and a 16p11.2 deletion syndrome

    Hoytema van Konijnenburg, E. M. M., Luirink, I. K., Schagen, S. E. E., Engelen, M., Berendse, K., Poll-The, B. T. & Chegary, M., Jun 2020, In: Molecular genetics and metabolism reports. 23, 100590.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry

    Luirink, I. K., Hutten, B. A., Greber-Platzer, S., Kolovou, G. D., Dann, E. J., de Ferranti, S. D., Taylan, C., Bruckert, E., Saheb, S., Oh, J., Driemeyer, J., Farnier, M., Pape, L., Schmitt, C. P., Novoa, F. J., Maeser, M., Masana, L., Shahrani, A., Wiegman, A. & Groothoff, J. W., Apr 2020, In: Atherosclerosis. 299, p. 24-31 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Statins for Familial Hypercholesterolemia from Childhood. Reply

    Luirink, I. K., Kusters, D. M. & Hutten, B. A., 30 Jan 2020, In: New England journal of medicine. 382, 5, p. 488-489 2 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  11. Diagnosis of familial hypercholesterolemia in children: Cascade screening from theory to practice

    Luirink, I. K., 2020, 3 ed. 160 p.

    Research output: ThesisPhd-Thesis - Research and graduation internal

  12. 2019
  13. 20-Year follow-up of statins in children with familial hypercholesterolemia

    Luirink, I. K., Wiegman, A., Kusters, D. M., Hof, M. H., Groothoff, J. W., de Groot, E., Kastelein, J. J. P. & Hutten, B. A., 2019, In: New England journal of medicine. 381, 16, p. 1547-1556

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 Next

ID: 71347